Shire Ends Humira Biosimilar Program, Returns Candidate to Momenta
By

By
Shire has decided to terminate its collaboration with Momenta Pharmaceuticals, a Cambridge, Massachusetts-based biotechnology company, to develop and commercialize M923, a proposed biosimilar referencing AbbVie’s Humira (adalimumab), an anti-tumor necrosis…

Amgen, Arrowhead Form RNAi Cardiovascular Pacts in $674 Million Deal
By

By
Amgen has formed two license and collaboration agreements with Arrowhead Pharmaceuticals, a Pasadena, California-based biotechnology company, to develop and commercialize RNA interference (RNAi) therapies for cardiovascular disease using Arrowhead’s proprietary subcutaneous…

AbbVie Opens Small-Molecule Manufacturing Facility in Singapore, Part of a $320 Million Investment
By

By
AbbVie has opened a small-molecule manufacturing facility in Singapore as part of a combined $320 million investment to expand small-molecule and biologics manufacturing in Singapore. The facility represents the company’s first…

BMS, GSK, Janssen, and Sanofi Lead Pipeline News
By

By
A roundup of the latest market developments from the pipelines of the pharmaceutical majors and other related news, featuring news from Bristol-Myers Squibb, GlaxoSmithKline, Janssen, Sanofi, Biogen, Gilead, AstraZeneca, and…

Batavia Biosciences, Gates Foundation Partner for Manufacturing Rotavirus Vaccine
By

By
Batavia Biosciences, a contract biologics manufacturer based in Leiden, The Netherlands, has received an $8 million grant from the Bill & Melinda Gates Foundation to develop a low-cost manufacturing process…

Systech, Servicepoint Partner in Serialization
By

By
Systech International, a Princeton, New Jersey-based company focused on brand protection technologies, has formed a strategic partnership with Servicepoint, a Kuopio, Finland-based supplier of serialization automation, allowing Servicepoint to act…

Dow, Colorcon Extend Scope of Controlled-Release Alliance
By

By
The Dow Chemical Company and Colorcon have broadened an existing controlled-release alliance to include Dow’s advanced technology-based pharmaceutical excipients, effective in January 2017. The alliance currently provides controlled-release technologies from…

R-Pharm, GE Partner for New Production Line
By

By
R-Pharm, a Yaroslavl, Russia-based pharmaceutical company, has opened a new production line for therapeutic proteins at its facility in Yaroslavl with the FlexFactory integrable platform, developed by GE Healthcare’s life…

Innova Biosciences Launches Magnetic Purification System
By

By
Innova Biosciences, a Cambridge, UK-based provider of bioconjugation products and services, has launched the AbPure magnetic purification system. The system is based on Protein A magnetic beads, which have an…

MilliporeSigma Launches Parvovirus Removal System
By

By
MilliporeSigma has launched the Viresolve Pro Shield H system for removing parvoviruses from therapeutic protein feed streams. The Viresolve Pro Shield H system is designed as a prefilter with Viresolve…